Iberogast

Iberogast, the active ingredient in Iberogast, is a herbal combination presented as an oral liquid for oral use. It is intended to alleviate functional gastrointestinal discomfort, such as dyspepsia and irritable bowel syndrome, in adult patients. It is formulated to target the upper gastrointestinal tract, helping to normalize motility and reduce visceral hypersensitivity.

GNH USA supplies Iberogast as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to diverse markets.

Iberogast is used to support the gastrointestinal tract in functional digestive disorders. - Functional dyspepsia: reduces epigastric pain and fullness, improving meal tolerance. - Irritable bowel syndrome: alleviates abdominal cramping and irregular bowel movements. - Upper abdominal discomfort: eases bloating and nausea associated with mild gastric irritation.

Iberogast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Mild gastrointestinal upset: occasional nausea or stomach discomfort. - Altered taste perception: transient metallic or bitter taste. - Skin reactions: mild rash or itching at the site of contact. - Headache: occasional mild headache. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Hepatic injury: rare cases of liver enzyme elevation. - Severe skin eruption: such as Stevens‑Johnson syndrome. - Angioedema: swelling of face, lips, or throat. - Persistent vomiting: prolonged emesis beyond initial adjustment period.

Before using Iberogast, consider the following precautions: - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use with caution and under medical advice. - Known allergy: avoid if hypersensitive to any herbal component. - Severe liver disease: use only under physician supervision. - Concomitant medications: discuss potential interactions with a doctor. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Iberogast may interact with other medicines; monitor accordingly.

Major Interactions (Avoid): - Hepatotoxic drugs (e.g., high‑dose acetaminophen): increased risk of liver injury. - Other herbal preparations containing similar constituents: potential additive effects. - Anticoagulants (e.g., warfarin): possible enhanced bleeding risk.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may reduce Iberogast efficacy. - Antispasmodics: additive antispasmodic effect could cause excessive gut slowing. - CYP450 substrates: possible alteration of metabolism for drugs processed by these enzymes.